These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7871251)

  • 1. Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro.
    Jarvis GE; Evans RJ
    Res Vet Sci; 1994 Nov; 57(3):317-24. PubMed ID: 7871251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro.
    Jarvis GE; Evans RJ
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):194-8. PubMed ID: 8735817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ADP in endotoxin-induced equine platelet activation.
    Jarvis GE; Evans RJ; Heath MF
    Eur J Pharmacol; 1996 Nov; 315(2):203-12. PubMed ID: 8960885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of aspirin and paracetamol on the aggregation of equine blood platelets.
    Heath MF; Evans RJ; Poole AW; Hayes LJ; McEvoy RJ; Littler RM
    J Vet Pharmacol Ther; 1994 Oct; 17(5):374-8. PubMed ID: 7853463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia.
    Carrick JB; Morris DD; Moore JN
    Equine Vet J; 1993 Mar; 25(2):152-7. PubMed ID: 8385601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin and dietary amines may increase plasma 5-hydroxytryptamine in the horse.
    Bailey SR; Cunningham FM; Elliott J
    Equine Vet J; 2000 Nov; 32(6):497-504. PubMed ID: 11093623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation of equine platelets by PAF (platelet-activating factor).
    Suquet CM; Leid RW
    Inflammation; 1983 Jun; 7(2):197-203. PubMed ID: 6862593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse.
    Foster AP; Lees P; Andrews MJ; Cunningham FM
    Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-tyrosine kinase p72syk is activated by platelet activating factor in platelets.
    Rezaul K; Yanagi S; Sada K; Taniguchi T; Yamamura H
    Thromb Haemost; 1994 Dec; 72(6):937-41. PubMed ID: 7740467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism and characteristics of platelet activation by haematin.
    Neely SM; Gardner DV; Reynolds N; Green D; Ts'ao CH
    Br J Haematol; 1984 Oct; 58(2):305-16. PubMed ID: 6383458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of platelets in aspirin-sensitive bronchoconstriction in the guinea-pig; interactions with salicylic acid.
    Lefort J; Vargaftig BB
    Br J Pharmacol; 1978 May; 63(1):35-42. PubMed ID: 647162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-endotoxin interaction: a review.
    Semeraro N; Fumarola D; Telesforo P; Vermylen J
    Boll Ist Sieroter Milan; 1976; 55(6):577-86. PubMed ID: 798597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and biochemical characterization of immunologically derived equine platelet-activating factor.
    Wimberly HC; Slauson DO; Neilsen NR
    Vet Pathol; 1985 Jul; 22(4):375-86. PubMed ID: 4035942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet function.
    Weiss DJ; Evanson OA; Wells RE
    Am J Vet Res; 1997 May; 58(5):457-60. PubMed ID: 9140550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The periodontal pathogen Porphyromonas gingivalis sensitises human blood platelets to epinephrine.
    Nylander M; Lindahl TL; Bengtsson T; Grenegård M
    Platelets; 2008 Aug; 19(5):352-8. PubMed ID: 18791941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    Thromb Res; 1991 Feb; 61(3):261-9. PubMed ID: 2028445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextran-70 inhibits equine platelet aggregation induced by PAF but not by other agonists.
    Heath MF; Evans RJ; Hayes LJ
    Equine Vet J; 1998 Sep; 30(5):408-11. PubMed ID: 9758098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin-induced platelet activation in human whole blood in vitro.
    Csako G; Suba EA; Elin RJ
    Thromb Haemost; 1988 Jun; 59(3):378-82. PubMed ID: 3055412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen induced human platelet aggregation: serotonin receptor antagonism retards aggregate growth in vitro.
    Menys VC
    Cardiovasc Res; 1993 Nov; 27(11):1916-9. PubMed ID: 8287397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.